NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY), Alexion Pharmaceuticals, Inc. (ALXN): Three Justifications for the High Cost of Gattex
NPS Pharmaceuticals, Inc.
Posts Tagged ‘NPS Pharmaceuticals Inc. (NPSP)’
Cardinal Health, Inc. (CAH), NPS Pharmaceuticals, Inc. (NPSP), Anacor Pharmaceuticals Inc (ANAC): Checking Back In On Michael Castor’s Favorite Healthcare Trio
We discussed Michael Castor's Sio Capital earlier this summer, and in case you need convincing of why we called him "the next David Einhorn," give this April analysis a look...
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we've seen from the smart money, out of the entire stock market universe and the 500+ elite...
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases
There are few times when your doctor or physician will utter the phrase, "I don't know" to a patient, but when you're dealing with the rarest of diseases, then all bets are off...
Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)
Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don't have to imagine it.
Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)
In the eyes of most traders, hedge funds are seen as worthless, old financial tools of the past.
NPS Pharmaceuticals, Inc. (NPSP), Pfizer Inc. (PFE): The Profitable Business of Developing Orphan Drugs
"Making every patient count" is a catchy phrase that is perhaps most meaningful for biotech companies like NPS Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. (ACHN): Are Hedge Funds Right About This Stock?
To most stock holders, hedge funds are seen as underperforming, old financial tools of years past.
NPS Pharmaceuticals, Inc. (NPSP), Vertex Pharmaceuticals Incorporated (VRTX): Double-Digit Returns from the Biotechnology Strategy
Investments in biotechnology by the average investor tend to deliver hit or miss returns over time.
Amgen, Inc. (AMGN), Regeneron Pharmaceuticals Inc (REGN), NPS Pharmaceuticals, Inc. (NPSP): Can These Biotechs Continue to Climb?
Two high-flying biotech stocks of late are NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) .
Puma Biotechnology Inc (PBYI), Achillion Pharmaceuticals, Inc. (ACHN): Here is What Hedge Funds Think About NPS Pharmaceuticals, Inc. (NPSP)
According to most investors, hedge funds are perceived as worthless, old financial tools of years past.
Orphan Drug Is Headed Back to Its Parent: NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is bringing its kids home.
It’s Time for AstraZeneca plc (ADR) (AZN) to Save Its Future
The hits keep coming at AstraZeneca plc (ADR) (NYSE:AZN).
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs -- medications meant for small patient populations with rare, dangerous diseases -- can be a rewarding business for biotech firms that strike gold.
3 Stocks to Get on Your Watchlist: NPS Pharmaceuticals, Inc. (NPSP) and More
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
5 Health Care Stocks Slumping in 2013: NPS Pharmaceuticals, Inc. (NPSP), OraSure Technologies, Inc. (OSUR)
Stocks are rolling along unchallenged, surging to highs not seen since 2007.
7 Biotech Stocks Trading At Steep Discount To Target Price
Last year we screened US-traded biotech stocks for those trading at the steepest discount to the most pessimistic analyst target prices.
